







A delegation from the Office of the Director of Public Prosecution (ODPP) led by Hon. Lady Justice Jane Frances Abodo (Centre) visited the URSB offices for a benchmarking tour.
A high-level delegation of Permanent Secretaries and officials from the Chandler Institute of Governance in Singapore on a learning visit to URSB
On 13th March 2025, diplomats, government officials, and business leaders convened at Uganda Business Facilitation Centre to champion reforms, strengthen global partnerships, and promote Uganda as a top investment destination.
On 12th March 2025, at the Uganda Business Facilitation Center in Kololo, the Registrar General and the Presidential Adviser on Creatives discussed boosting creative sector monetization through improved stakeholder coordination and URSB reforms ahead of World Intellectual Property Day.


URSB Partners with Dei Biopharma to Advance Innovation through Intellectual Property Protection
To foster scientific innovation and strengthen intellectual property (IP) protection, the Uganda Registration Services Bureau (URSB) conducted a working visit to Dei Biopharma last week, an emerging pharmaceutical facility in Matugga Town Council.
Led by former Commissioner for Intellectual Property, Mr. Gilbert Agaba, the URSB team held discussions with Dei Biopharma’s leadership to explore ways of protecting and strategically managing the company’s intellectual property assets.
The visit follows international recognition of Dei Biopharma’s recent patent application in the U.S. for the world’s first universal Foot and Mouth Disease (FMD) vaccine.
URSB used the engagement to better understand the scope of pharmaceutical research being undertaken by Dei Biopharma and to identify how national IP systems can support such innovations. The discussions also touched on opportunities for collaboration on international IP filings, positioning Uganda as a leader in bioscience and pharmaceutical research.

Led by Dr. Matthias Magoola, the facility is positioned as a strategic national investment aligned with the government’s science, technology, and innovation agenda. It aims to significantly decrease Uganda’s reliance on imported drugs, boost local pharmaceutical capacity, and make medicines more affordable across the region.
Dei Biopharma produces a diverse range of pharmaceuticals, including those for infectious diseases, cancer, and other chronic illnesses.
URSB commended Dei Biopharma for its scientific leadership and efforts in pharmaceutical development. The bureau pledged continued technical support to innovators across the country in safeguarding their creations.